Biosergen AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	85	93	124	45	45	152
Market Cap Growth	-15.42%	-25.43%	179.03%	0.12%	-70.75%	-
Enterprise Value	70	70	114	38	35	115
Last Close Price	36.20	39.52	53.00	88.00	105.00	542.00
PB Ratio	10.47	11.43	2.58	21.08	1.96	7.53
P/TBV Ratio	10.47	11.43	2.58	21.08	1.96	7.53
Net Debt / Equity Ratio	-1.89	-1.89	-1.05	-0.89	-1.29	-1.07
Quick Ratio	1.95	1.95	10.92	1.34	3.03	3.15
Current Ratio	1.95	1.95	11.01	1.42	3.07	3.19
Return on Equity (ROE)	-144.93%	-144.93%	-76.29%	-217.09%	-158.27%	-
Return on Assets (ROA)	-68.46%	-68.46%	-39.86%	-83.14%	-67.42%	-
Return on Capital Employed (ROCE)	-389.70%	-389.70%	-39.80%	-1288.50%	-149.70%	-202.10%
Earnings Yield	-48.02%	-43.98%	-15.42%	-60.62%	-76.43%	-27.04%
Buyback Yield / Dilution	2.13%	2.13%	-370.34%	-63.31%	-11.05%	74.16%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.